HIGHLIGHTS
- who: Kaihang Zhong from the Sichuan University, China have published the research: Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy, in the Journal: (JOURNAL) of October/11,/2018
- how: Showed that PD-L1 expression was positive (Ventana SP263 Tumor cell Proportion Score=5% Immune cell Proportion Score=0%).
SUMMARY
Hepatocel lula r carcinoma (H CC) is a common gastrointestinal malignancy. Transarterial chemoembolization (TACE) is a standard treatment for unresectable HCC patients, but TACE showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.